The Carlyle Group Inc. (CG)
NASDAQ: CG · Real-Time Price · USD
43.15
-1.94 (-4.30%)
At close: Mar 28, 2025, 4:00 PM
43.06
-0.09 (-0.22%)
After-hours: Mar 28, 2025, 7:49 PM EDT
The Carlyle Group Employees
The Carlyle Group had 2,300 employees as of December 31, 2024. The number of employees increased by 100 or 4.55% compared to the previous year.
Employees
2,300
Change (1Y)
100
Growth (1Y)
4.55%
Revenue / Employee
$2,060,826
Profits / Employee
$443,652
Market Cap
15.43B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,300 | 100 | 4.55% |
Dec 31, 2023 | 2,200 | 100 | 4.76% |
Dec 31, 2022 | 2,100 | 250 | 13.51% |
Dec 31, 2021 | 1,850 | 25 | 1.37% |
Dec 31, 2020 | 1,825 | 50 | 2.82% |
Dec 31, 2019 | 1,775 | 175 | 10.94% |
Dec 31, 2018 | 1,600 | 0 | - |
Dec 31, 2017 | 1,600 | 0 | - |
Dec 31, 2016 | 1,600 | -100 | -5.88% |
Dec 31, 2015 | 1,700 | 50 | 3.03% |
Dec 31, 2014 | 1,650 | 150 | 10.00% |
Dec 31, 2013 | 1,500 | 100 | 7.14% |
Dec 31, 2012 | 1,400 | 300 | 27.27% |
Jun 30, 2011 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
CG News
- 8 days ago - UK's Energean terminates Carlyle deal - Reuters
- 9 days ago - Carlyle seeks buyers for Colombian oil producer - Reuters
- 9 days ago - SoftBank Group to Acquire Ampere Computing - Business Wire
- 25 days ago - Carlyle to ramp up pace of IPOs as it eyes up to $5 billion of exits in 2025 - Reuters
- 4 weeks ago - NSM Insurance Group Announces Definitive Agreement for New Mountain Capital to Acquire Its U.S. Commercial Insurance Division - PRNewsWire
- 5 weeks ago - Big 4 Private Equity Firms In Brighter Mood; Falling Investment In Biotech - Seeking Alpha
- 5 weeks ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc. - PRNewsWire
- 5 weeks ago - bluebird bio Stock Alert - Kehoe Law Firm, P.C. Investigating the Fairness and Adequacy of the Proposed Acquisition of bluebird bio by Investment Firms in Collaboration with Biotech Execs - Accesswire